Autism Study on Promising Supplement Approved

What:    Randomized, double-blind, placebo-controlled clinical study.
Why:     To assess whether activated liquid zeolite is effective in reducing behavior disorder in children on the autism spectrum.
Where:  Plano, Texas and Baton Rouge, Louisiana, plus 20 to 40 non-local participants.
When:   Accepting participants now, with rolling enrollment.

About Liquid Zeolite:
Liquid Zeolite, a safe, natural, inert mineral supplement, has generated many encouraging reports from parents of autistic children. This type of zeolite, clinoptilolite, is purified with a patented process and suspended in solution.  The FDA as rated Liquid Zeolite as G.R.A.S. (Generally Recognized As Safe).  As one of few natural minerals with a negative charge, zeolite effectively pulls toxins from the system, helping the body excrete them normally.  Liquid Zeolite has been shown in previous studies to be most effective against heavy metals like mercury, lead, and arsenic.

About the Study:
A randomized, double-blind, placebo-controlled clinical study designed to evaluate the benefits of Liquid Zeolite on Autism Spectrum Disorders was approved by BioMed IRB on June 7, 2006.  The study is recruiting 80 subjects between the ages of 3 and 18 years of age. This group will be divided into two groups for a period of ninety days. Those that take the placebo will then be tracked for another ninety days while taking the Liquid Zeolite. Both groups will be measured using a variety of established instruments for autism diagnosis and treatment evaluation. A portion of the participants will receive a series of urine excretion tests designed to detect levels of heavy metal excretion. 

Study Inclusion Criteria includes:
• at least a two-month history of taking a multi-vitamin/supplement, which must continue during the study.
• no chelators for the month prior to the study.
• no changes during the study period in diet, treatments, interventions and medications.

Study Exclusion Criteria includes:
• no genetic defects such as Down Syndrome or Fragile X Syndrome
• no Tuberculosis.
• not less than 32 weeks gestation
• no diagnosis of cerebral palsy

Call to learn more about the study.

* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease, since only a synthetic DRUG can officially do that by law.